Home β€Ί Stock analysis β€Ί IMMP

Immutep (IMMP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

IMMP dips 0.3% to $3.20, 4 down days in a row. Closed at $3.20, -0.31% vs the prior close of $3.21. Day range $3.18–$3.27, opened at $3.27.

Last close$3.20-0.31%
Day range3.18–3.27
Open3.27
Volume11.74K
52-week range0.26–8.20
Avg volume (20d)151.11K

IMMP daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” IMMP dips 0.3% to $3.20, 4 down days in a row
Oct 15, 2026 β€” IMMP slides 5.0% to $3.21, 3 down days in a row
Oct 14, 2026 β€” IMMP slides 5.3% to $3.38
Oct 13, 2026 β€” IMMP dips 2.7% to $3.57
Oct 12, 2026 β€” IMMP rises 1.1% to $3.67
Oct 9, 2026 β€” IMMP slides 5.5% to $3.63, 3 down days in a row
Oct 8, 2026 β€” IMMP slides 5.4% to $3.84
Oct 7, 2026 β€” IMMP slides 6.5% to $4.06
Oct 6, 2026 β€” IMMP rises 1.6% to $4.34
Oct 5, 2026 β€” IMMP dips 1.8% to $4.27, 4 down days in a row
Oct 2, 2026 β€” IMMP slides 4.2% to $4.35, 3 down days in a row

IMMP latest news & SEC filings

Every SEC filing by or about IMMP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 14, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001193125-26-420840

Sep 22, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001193125-26-397189

Sep 11, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001193125-26-389402

Sep 2, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001193125-26-379062

Aug 3, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001193125-26-329120

Jul 14, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001193125-26-302281

Things to know before you trade IMMP

IMMP market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20263.273.273.183.2011.74K
Oct 15, 20263.313.313.063.2119.00K
Oct 14, 20263.483.543.363.3838.70K
Oct 13, 20263.603.703.443.5727.00K
Oct 12, 20263.573.703.563.6718.60K
Oct 9, 20263.793.793.553.6323.40K
Oct 8, 20264.024.103.803.8414.90K
Oct 7, 20264.284.314.044.069.60K
Oct 6, 20264.344.514.304.3411.60K
Oct 5, 20264.354.504.184.2725.20K
Oct 2, 20264.614.614.174.3548.70K
Oct 1, 20264.704.704.534.5411.00K
Sep 30, 20264.794.794.624.6510.50K
Sep 29, 20264.874.874.604.7134.00K
Sep 25, 20260.280.280.260.26649.30K
Sep 24, 20260.270.270.260.26241.30K
Sep 23, 20260.290.290.260.27751.30K
Sep 22, 20260.300.300.280.28143.20K
Sep 21, 20260.280.300.280.29356.70K
Sep 18, 20260.310.310.280.29576.50K

About Immutep

Immutep (IMMP) is listed on the Nasdaq and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in SYDNEY,, Australia. State of incorporation: Australia. Fiscal year ends June 30. SEC CIK 1506184.

IMMP board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Elisabeth Amanda BoyceDirectorApr 16, 2026
Russell J HowardDirectorApr 1, 2026
Pete A. MeyersDirectorApr 7, 2026
Frederic Joseph Daniel TriebelDirectorApr 1, 2026
Marc VoigtSee RemarksApr 13, 2026

Executive officers

NameTitleLatest filing
Deanne Diem MillerChief Operating OfficerApr 13, 2026
Christian MuellerChief Development OfficerApr 1, 2026
Marc VoigtSee RemarksApr 13, 2026
Stephan Karel Gerard WinckelsChief Medical OfficerApr 1, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

IMMP financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

IMMP earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on IMMP

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.